Cite
Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity.
MLA
Spósito, Pollyanna Álvaro, et al. “Ravuconazole Self-Emulsifying Delivery System: In Vitro Activity against Trypanosoma Cruzi Amastigotes and in Vivo Toxicity.” International Journal of Nanomedicine, vol. 12, May 2017, pp. 3785–99. EBSCOhost, https://doi.org/10.2147/IJN.S133708.
APA
Spósito, P. Á., Mazzeti, A. L., de Oliveira Faria, C., Urbina, J. A., Pound-Lana, G., Bahia, M. T., & Mosqueira, V. F. (2017). Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity. International Journal of Nanomedicine, 12, 3785–3799. https://doi.org/10.2147/IJN.S133708
Chicago
Spósito, Pollyanna Álvaro, Ana Lia Mazzeti, Caroline de Oliveira Faria, Julio A Urbina, Gwenaelle Pound-Lana, Maria Terezinha Bahia, and Vanessa Furtado Mosqueira. 2017. “Ravuconazole Self-Emulsifying Delivery System: In Vitro Activity against Trypanosoma Cruzi Amastigotes and in Vivo Toxicity.” International Journal of Nanomedicine 12 (May): 3785–99. doi:10.2147/IJN.S133708.